LEPRI, GEMMA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.642
EU - Europa 3.233
AS - Asia 3.136
SA - Sud America 360
Continente sconosciuto - Info sul continente non disponibili 156
AF - Africa 94
OC - Oceania 42
Totale 11.663
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.506
RU - Federazione Russa 1.100
CN - Cina 864
IT - Italia 835
SG - Singapore 794
PL - Polonia 461
HK - Hong Kong 406
VN - Vietnam 277
KR - Corea 263
BR - Brasile 252
IE - Irlanda 195
SE - Svezia 158
BD - Bangladesh 129
FR - Francia 109
IN - India 105
DE - Germania 102
FI - Finlandia 97
JP - Giappone 90
CA - Canada 75
GB - Regno Unito 64
AU - Australia 40
ID - Indonesia 40
JO - Giordania 39
AR - Argentina 30
MX - Messico 29
TR - Turchia 29
IQ - Iraq 24
EG - Egitto 22
ES - Italia 21
EC - Ecuador 20
BO - Bolivia 17
ZA - Sudafrica 16
CH - Svizzera 14
CO - Colombia 14
NL - Olanda 14
CI - Costa d'Avorio 11
IL - Israele 9
AE - Emirati Arabi Uniti 8
CR - Costa Rica 8
MA - Marocco 8
UA - Ucraina 8
BE - Belgio 7
LT - Lituania 7
NG - Nigeria 7
PE - Perù 7
PK - Pakistan 7
VE - Venezuela 7
BJ - Benin 6
PT - Portogallo 6
RO - Romania 6
AT - Austria 5
CL - Cile 5
PH - Filippine 5
PY - Paraguay 5
RS - Serbia 5
SA - Arabia Saudita 5
TW - Taiwan 5
UZ - Uzbekistan 5
AL - Albania 4
AZ - Azerbaigian 4
JM - Giamaica 4
KE - Kenya 4
KZ - Kazakistan 4
MY - Malesia 4
TN - Tunisia 4
BG - Bulgaria 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
LV - Lettonia 3
NP - Nepal 3
OM - Oman 3
PA - Panama 3
PR - Porto Rico 3
UY - Uruguay 3
AO - Angola 2
BH - Bahrain 2
CG - Congo 2
GT - Guatemala 2
HU - Ungheria 2
KG - Kirghizistan 2
LB - Libano 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
SC - Seychelles 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BM - Bermuda 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
EU - Europa 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
IR - Iran 1
KH - Cambogia 1
Totale 11.498
Salva come PNG Salva come JPEG
Città #
Santa Clara 958
Ashburn 659
Singapore 589
Warsaw 443
Hong Kong 351
Fairfield 281
Seoul 249
Hefei 237
Chandler 194
San Jose 190
Dublin 189
Beijing 158
Florence 144
Woodbridge 137
Milan 119
Seattle 118
Cambridge 108
Council Bluffs 107
Houston 105
Ho Chi Minh City 90
Los Angeles 80
Wilmington 77
Lawrence 70
Altamura 69
Rome 66
Buffalo 64
Moscow 63
New York 63
Lauterbourg 62
Princeton 56
Hanoi 51
Munich 50
Ann Arbor 48
Boston 46
Tokyo 45
Mumbai 41
The Dalles 40
Chicago 39
Helsinki 39
Melbourne 38
Kent 34
Jakarta 28
Shanghai 26
Naples 25
Clifton 24
Turin 24
Paris 23
Pune 23
Dallas 22
São Paulo 22
Toronto 22
Turku 22
Boardman 20
Guayaquil 16
Katsushika 16
Koishikawa 15
Phoenix 15
Da Nang 14
La Paz 14
Lappeenranta 14
London 14
Montreal 14
San Diego 14
Bengaluru 13
Bologna 13
Salt Lake City 13
Chennai 12
Dong Ket 12
Frankfurt am Main 12
Johannesburg 12
Redondo Beach 12
Tianjin 12
West Jordan 12
Abidjan 11
Falls Church 11
Norwalk 11
Orem 11
Shenzhen 11
Cairo 10
Charleston 10
Fiesole 10
Figino 10
Genoa 10
Incheon 10
Medford 10
Bari 9
Bern 9
Catania 9
Guangzhou 9
Haiphong 9
Mexico City 9
Newark 9
Palermo 9
Rio de Janeiro 9
Secaucus 9
Brooklyn 8
Düsseldorf 8
Hải Dương 8
Venice 8
Abuja 7
Totale 7.371
Salva come PNG Salva come JPEG
Nome #
Systemic sclerosis: one year in review 2024 384
Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis 333
Digital ulcers as a sentinel sign for early internal organ involvement in very early systemic sclerosis 281
Decreased expression of the endothelial cell-derived factor EGFL7 in systemic sclerosis: potential contribution to impaired angiogenesis and vasculogenesis 269
The "myth" of loss of angiogenesis in systemic sclerosis: A pivotal early pathogenetic process or just a late unavoidable event? 243
18F-fluorodeoxyglucose positron-emission tomography/CT and lung involvement in systemic sclerosis 238
Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells 217
The Role of Adipokines between Genders in the Pathogenesis of Osteoarthritis 209
AB0976 Association of Vitamin D Receptor Polymorphisms with Juvenile Idiopathic Arthritis (JIA) 208
Decrease of LL-37 in systemic sclerosis: a new marker for interstitial lung disease? 205
Evidence for a Derangement of the Microvascular System in Patients with a Very Early Diagnosis of Systemic Sclerosis 192
EFFICACY OF A SELF-TREATMENT PROTOCOL FOR FACE AND TEMPOROMANDIBULAR JOINTS REHABILITATION IN SYSTEMIC SCLEROSIS 191
Pregnancy in systemic sclerosis (SSc): results of systematic review and meta-analysis 191
Enthesopathy and involvement of synovio-entheseal complex in systemic sclerosis: an ultrasound pilot study 190
POS0613 THE ROLE OF MICROBIOTA IN DIFFERENT DISEASE STAGES OF SYSTEMIC SCLEROSIS: A POSSIBLE IMPACT IN GASTROINTESTINAL TRACT DISEASE ACTIVITY? 187
The differential crosstalk of the skin-gut microbiome axis as a new emerging actor in systemic sclerosis 187
Clinical-Serological Characterization and Treatment Outcome of a Large Cohort of Italian Children with Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal Infection and Pediatric Acute Neuropsychiatric Syndrome 187
DECIPHERING THE GUT MICROBIOTA OF VERY EARLY SYSTEMIC SCLEROSIS (VEDOSS) PATIENTS: A TAXONOMIC AND FUNCTIONAL CHARACTERIZATION 185
Systemic Sclerosis Association with Malignancy 177
Antioxidant agents help primary Raynaud's phenomenon 176
The safety of iloprost in systemic sclerosis in a real-life experience 175
The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis-Interstitial Lung Disease in the European Scleroderma Trial and Research Database 172
THE CROSSTALK OF THE SKIN-ORAL-GUT MICROBIOME AXIS IN LIMITED AND DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS 169
Evidence for oesophageal and anorectal involvement in very early systemic sclerosis (VEDOSS): report from a single VEDOSS/EUSTAR centre 162
Effects of rituximab in connective tissue disorders related interstitial lung disease 159
Preliminary analysis of the Very Early Diagnosis of Systemic Sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis. 158
Lung ultrasound B-lines in systemic sclerosis: cut-off values and methodological indications for interstitial lung disease screening 158
The role of lung biopsy for diagnosis and prognosis of interstitial lung disease in systemic sclerosis: a systematic literature review 157
Prognostic value of lung ultrasound B-lines in systemic sclerosis 157
Oral lactobacillus species in systemic sclerosis 157
Potential Role of JAK Inhibitors in the Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease: A Narrative Review from Pathogenesis to Real-Life Data 156
The Potential Role of Butyrate in the Pathogenesis and Treatment of Autoimmune Rheumatic Diseases 154
Increased plasma levels of the VEGF165b splice variant are associated with the severity of nailfold capillary loss in systemic sclerosis 154
Long-term retention rate, adverse event temporal patterns and rescue treatment strategies of mycophenolate mofetil in systemic sclerosis: insights from real-life 153
Menstruation-Related Disorders-Dysmenorrhea and Heavy Bleeding-as Significant Epiphenomena in Women With Rheumatic Diseases 153
Decreased expression of the endothelial cell-derived factor EGFL7 contributes to impaired angiogenesis and vasculogenesis in systemic sclerosis 151
Combination therapy with Bosentan and Sildenafil improves Raynaud’s phenomenon and fosters the recovery of microvascular involvement in systemic sclerosis 151
The renal resistive index: A new biomarker for the follow-up of vascular modifications in systemic sclerosis 151
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology 149
The Yin-Yang Pharmacomicrobiomics on Treatment Response in Inflammatory Arthritides: A Narrative Review 149
The systemic sclerosis patient in the COVID-19 era: the challenging crossroad between immunosuppression, differential diagnosis and long-term psychological distress 149
Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS) 149
Bosentan blocks the antiangiogenic effects of sera from systemic sclerosis patients: an in vitro study 147
The Use and Utility of Machine Learning in Achieving Precision Medicine in Systemic Sclerosis: A Narrative Review 144
Evaluation of autoimmune phenomena in patients with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) 143
One year in review 2021: systemic sclerosis 142
ORAL MICROBIOME IN RHEUMATIC DISEASES.WHAT INVOLVEMENT? 142
AB0481 Vitamin D Levels in Children, Adolescents, and Young Adults with Juvenile Onset Systemic Lupus Erythematosus: A Transversal Study 141
THE FIRST 1000 DAYS OF LIFE AND REPRODUCTIVE DISORDERS IN WOMAN WITH RHEUMATIC DISEASE (RDS) 139
SAT0505 Severe Vitamin D Deficiency in Patients with Kawasaki Disease: its Possible Role in the Risk to Develop Coronary Artery Damage 138
Cross-Sectional Evaluation of Plasma Vitamin D Levels in a Large Cohort of Italian Patients with Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections 138
PReS-FINAL-2053: Vitamin D receptor polymorphisms in a cohort of Italian patients with juvenile idiopathic arthritis 134
Very early versus early disease: the evolving definition of the 'many faces' of systemic sclerosis. 133
Stressful life events at the onset and during the evolution of systemic sclerosis 131
The role of ultrasound in systemic sclerosis: On the cutting edge to foster clinical and research advancement 130
Systemic sclerosis and primary biliary cholangitis: An overlapping entity? 129
Gut microbiota in very early systemic sclerosis: the first case-control taxonomic and functional characterisation highlighting an altered butyric acid profile 128
Practice pattern for the use of intravenous iloprost for the treatment of peripheral vasculopathy in systemic sclerosis: A case–control study from the Italian national multicenter “SPRING” (Systemic Sclerosis Progression InvestiGation) Registry 125
Severe vitamin D deficiency in patients with Kawasaki disease: a potential role in the risk to develop heart vascular abnormalities? 123
Recent advances steer the future of systemic sclerosis toward precision medicine 121
Systemic sclerosis and primary biliary cholangitis: Longitudinal data to determine the outcomes 119
Lung vascular changes as biomarkers of severity in systemic sclerosis–associated interstitial lung disease 117
Evidence for esophageal and anorectal involvement in very early systemic sclerosis (VEDOSS): report from a single VEDOSS/EUSTAR centre 117
Early diagnosis of systemic sclerosis, where do we stand today? 104
Very early and early diagnosis of systemic sclerosis 96
The Burden of Interstitial Lung Involvement in Rheumatoid Arthritis: Could Lung Ultrasound Have a Role in Its Detection? A Literature Review 86
Nintedanib in rheumatoid arthritis related interstitial lung disease: real-world safety profile and risk of side effects and discontinuation 80
Systemic sclerosis and environment: an intriguing and still debated association 71
The emerging challenge of pain in systemic sclerosis: Similarity to the pain experience reported by Sjőgren’s syndrome patients 70
Mesenchymal Stem-Cell-Derived Exosomes and MicroRNAs: Advancing Cell-Free Therapy in Systemic Sclerosis 53
MYCOPHENOLATE MOFETIL TREATMENT REDUCES THE RISK OF TREATMENT ESCALATION DUE TO VASCULAR COMPLICATIONS IN LIMITED CUTANEOUS SYSTEMIC SCLEROSIS: EMULATION OF A TARGET TRIAL FROM ITALIAN RHEUMATOLOGY SOCIETY SPRING REGISTRY 51
Systemic sclerosis: one year in review 2022 47
Gastrointestinal involvement in very early and established systemic sclerosis: insights from the SPRING-SIR national Italian registry 45
Systemic sclerosis: one year in review 2024 41
Ultrasound evaluation of bowel vasculopathy in systemic sclerosis 34
First‐line diagnostic tests to intercept primary heart involvement in systemic sclerosis: Clinical associations from the SPRING‐SIR registry 33
Systemic sclerosis: one year in review 2025 25
Nintedanib in Rheumatoid Arthritis-Related Interstitial Lung Disease: Real-World Safety Profile and Risk of Side Effects and Discontinuation 25
Pulmonary Arterial Hypertension Incidence in Patients With Systemic Sclerosis Treated With Bosentan for Digital Ulcers: Evidence From the SPRING-SIR Registry 23
Lung involvement in psoriatic arthritis patients: cross-sectional study on prevalence, clinical characteristics, and risk factors of a neglected comorbidity 19
Elderly-onset systemic sclerosis defines a distinct clinical subset: analysis from the SPRING registry of the Italian Society for Rheumatology 18
Rare in the rare: Kikuchi-Fujimoto disease associated with connective tissue disorders. A report of our experience 17
Age and onset timing of Raynaud’s phenomenon and first non-Raynaud symptom as prognostic factors in systemic sclerosis: a retrospective analysis from the Italian national multicenter Systemic Sclerosis Progression INvestiGation registry of the Italian Society for Rheumatology (SPRING-SIR) 15
Prevalence, distribution and associations of the scleroderma capillaroscopic patterns: new insights from the Italian SPRING-SIR registry 14
Nintedanib in Rheumatoid Arthritis-Related Interstitial Lung Disease: Real-World Safety Profile and Risk of Side Effects and Discontinuation 11
Real-world effectiveness and retention rate of upadacitinib in patients with rheumatoid arthritis: results from a multicentre study 11
Totale 11.663
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.038
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.038
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022280 0 13 29 9 19 27 2 24 19 14 32 92
2022/2023900 90 212 34 45 57 139 123 44 84 18 28 26
2023/2024468 11 47 61 16 35 80 22 88 6 56 30 16
2024/20253.319 88 289 183 509 807 416 164 233 153 116 161 200
2025/20264.783 496 575 470 364 597 155 462 220 298 310 312 524
2026/2027308 199 109 0 0 0 0 0 0 0 0 0 0
Totale 11.663